PPB expands supply chain oversight to safeguard medicine quality
The Pharmacy and Poisons Board (PPB) is expanding oversight of the storage, transportation and distribution of medicines and other health products through a planned nationwide compliance inspection targeting public and private hospital pharmacies, retail pharmacies, pharmaceutical wholesalers and transporters. The exercise forms part of the Board’s continued efforts to strengthen compliance with…
The Pharmacy and Poisons Board (PPB) is expanding its supply chain oversight to safeguard the quality of medicines and other health products across the nation. This initiative aims to ensure that health products retain their quality, safety, and effectiveness throughout the supply chain by strengthening compliance with Good Storage and Distribution Practices.
The expanded inspection will target public and private hospital pharmacies, retail pharmacies, pharmaceutical wholesalers, and transporters, focusing on storage conditions, temperature and humidity controls, transportation practices, documentation, stock management, product traceability, and procedures for managing product complaints and recalls.
Dr Ahmed I. Mohamed, Chief Executive Officer of PPB, emphasizes the importance of maintaining product quality from manufacturing to patient use, especially for temperature-sensitive products like vaccines, insulin, and biological medicines.
Brief written by urgent.news from KBC's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
